Skip to main content
CNO
NYSE Finance

CNO Financial Lifts Full-Year Operating EPS View by 8% After a 45% Q2 Surge

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Insurance Stocks · Financial
Sentiment info
Positive
Importance info
8
Price
$56
Mkt Cap
$4.993B
52W Low
$35.24
52W High
$54.09
52W Position info
59% above low
Off High info
at 52W high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

CNO sits 59% above its 52-week low of $35.24.

Summary

CNO Financial reported Q2 operating EPS of $1.26, up 45% YoY, and raised full-year 2026 operating EPS guidance by 8% to $4.60–$4.80. The quarter marked the 16th consecutive period of insurance sales growth, with records in Worksite NAP, annuity collected premiums, and client assets.


Key Events · Earnings and Guidance · CNO

  • Q2 Operating EPS Up 45%

    Driven by higher insurance product margins and net investment income, operating EPS reached $1.26, compared with $0.87 in Q2 2025.

  • Full-Year Guidance Raised 8%

    Reflecting strong first-half execution and sustained sales momentum, 2026 operating EPS guidance was increased to $4.60–$4.80 from the prior midpoint.

  • 16th Consecutive Quarter of Sales Growth

    Total new annualized premiums (NAP) rose 7% to $127.7M, with records in Worksite Division NAP, annuity collected premiums, and client assets in brokerage and advisory.

  • Capital Return Continues

    The company repurchased $60M of common stock (1.3M shares at $46.57 avg) and paid $16.8M in dividends; $300.4M remains under repurchase authorization.


Analysis · CNO · Finance

A standout quarter saw operating EPS jump 45% year-over-year, fueled by broad-based insurance sales growth and solid underwriting. Management raised the full-year operating EPS guide by 8% at the midpoint, signaling confidence in sustained momentum. The 16th consecutive quarter of sales growth and record production metrics underscore the durability of the middle-market franchise. With shares trading near a 52-week high, the raised guidance and robust capital return—$60M in buybacks—reinforce the positive thesis, though the stock already reflects much of the optimism.

At the time of this filing, CNO was trading at $56.00 on NYSE in the Finance sector, with a market capitalization of approximately $5B. The 52-week trading range was $35.24 to $54.09. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CNO - Latest Insights

CNO
Jul 30, 2026, 4:25 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $56.00
Real-time Price: $56.00 info
Change: $0 (0%) info
Market Cap: $4.993B info
CNO
May 07, 2026, 4:21 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $45.89
Real-time Price: $56.00 info
Change: +$10.11 (+22%) info
Market Cap: $4.993B info
CNO
Apr 30, 2026, 4:29 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $44.45
Real-time Price: $56.00 info
Change: +$11.55 (+26%) info
Market Cap: $4.993B info
CNO
Mar 26, 2026, 4:13 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $40.96
Real-time Price: $56.00 info
Change: +$15.04 (+37%) info
Market Cap: $4.993B info
CNO
Feb 24, 2026, 4:54 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $41.62
Real-time Price: $56.00 info
Change: +$14.38 (+35%) info
Market Cap: $4.993B info